newsfilter
← Latest News
ACCESS Newswire·

Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026

Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma selected for presentation at a Presidential SymposiumModerna to host an investor event via webcast on